サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1574986

非識別化健康データ市場：データタイプ別、展開モード別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

De-identified Health Data Market, By Data Type, By Deployment Mode, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 260 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
非識別化健康データ市場：データタイプ別、展開モード別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年10月02日
発行: AnalystView Market Insights
ページ情報: 英文 260 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

非識別化健康データの市場規模は、2023年に75億4,909万米ドルとなり、2024年から2032年にかけてCAGR9.20％で拡大

非識別化健康データ市場 - 市場力学

個別化医療への注目の高まりが非識別化健康データ市場の需要を牽引

個別化医療への注目の高まりが、非識別化健康データ市場の需要を大きく促進しています。ヘルスケアプロバイダーが治療をカスタマイズするために患者データを利用することが増えているため、非識別化健康データのニーズが急増しています。米国保健福祉省の報告書によると、個別化医療は患者の転帰改善と医療費削減につながります。さらに、All of Us研究プログラムのようなイニシアチブは、個別化された治療アプローチを強化するために、多様な集団からデータを収集することを目指しています。IBMやGoogleなどの大手ハイテク企業は、AIや分析ツールに投資して、研究や臨床応用のために非識別化健康データを活用し、個別化治療の進歩を促進しています。この成長動向は、患者のプライバシーを維持しながらヘルスケアサービスを向上させる上で、安全でコンプライアンスに準拠したデータの取り扱いが果たす重要な役割を浮き彫りにしています。

非識別化健康データ市場 - 主要な洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024年～2032年）に約9.20%のCAGRで毎年成長すると予測されています。

データタイプ別では、電子カルテが2023年に最大の市場シェアを示すと予測されています。

展開モード別では、クラウドベースが2023年の主要タイプでした。

地域別では、北米が2023年に収益を生み出す主要市場です。

非識別化健康データ市場 - セグメンテーション分析：

世界の非識別化健康データ市場は、データタイプ、展開モード、用途、地域に基づいてセグメント化されます。

電子カルテ（EHR）は包括的な患者情報のため最優先されます。次いで、医療費に関する洞察を提供するヘルスケアデータ（Claims Data）、臨床データ（Clinical Data）、専門的な洞察を提供するゲノムデータ（Genomic Data）が続きます。

市場は、展開モードによって2つのカテゴリーに分けられます：オンプレミス型とクラウド型です。クラウドベースの展開が優先される理由は、その拡張性と費用対効果にあり、データへのアクセスが容易なためです。オンプレミス・ソリューションは、より多くの投資を必要とするものの、機密性の高い医療情報のセキュリティと管理が強化されるため、支持されています。

非識別化健康データ市場 - 地理的洞察

北米では、非識別化健康データ市場は多数のヘルスケアデータ企業や高度分析企業の本拠地である米国が主要企業です。米国では2022年に約220億米ドルの健康データ収入があり、データ主導のヘルスケアソリューションに多額の投資が行われています。欧州では、EUの一般データ保護規則（GDPR）が非識別化データの責任ある利用を促していることから市場が拡大しており、ドイツや英国などの国々がヘルスケアアナリティクス能力を拡大できるようになっています。一方、アジア太平洋地域は、インドや中国などの国々がデジタルヘルスへの取り組みに注力しており、有力な候補として浮上しています。インドのヘルスケアIT部門は2025年までに90億米ドルに成長すると予測されており、非識別化健康データに対する需要が高まっていることを示しています。ラテンアメリカも健康データの重要性を認識しており、ブラジルは公衆衛生向上のための非識別化データ利用を促進する健康データ法を導入しています。このような地域的な取り組みが、非識別化健康データの世界の状況を再形成しています。

非識別化健康データ市場 - 競合情勢：

非識別化健康データ市場では、北米が技術の進歩と強固なヘルスケアシステムに牽引され、依然として主要地域となっています。2023年1月、ヘルスケアサービス企業であるOptumは、ヘルスケアプロバイダーに高度なインサイトを提供することを目的として、非識別化健康データの提供を強化するための主要分析企業との戦略的提携を発表しました。一方、欧州では2023年3月、Siemens Healthineersと欧州のアナリティクス企業との間で、非識別化患者データを調査目的に活用し、患者の転帰を向上させるという重要な提携が行われました。アジア太平洋では、2022年後半に著名なヘルステック新興企業が現地のデータ分析企業を買収し、非識別化健康データ管理能力を拡大しました。さらに、非識別化健康データ市場の成長は、米国医療情報技術調整官事務所が健康データの責任ある利用を推進するなど、有利な規制によって支えられています。このような動きは、競合情勢のダイナミックな性質を反映しており、世界中でイノベーションとコラボレーションが重視されています。

目次

第1章 非識別化健康データ市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 非識別化健康データの主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 非識別化健康データ産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 非識別化健康データ市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 非識別化健康データ市場情勢

  • 非識別化健康データ市場シェア分析、2023年
  • 内訳データ：主要メーカー別
    • 既存企業の分析
    • 新興企業の分析

第7章 非識別化健康データ市場 - データタイプ別

  • 概要
    • セグメントシェア分析：データタイプ別
    • 電子健康記録（EHR）
    • クレームデータ
    • 臨床データ
    • ゲノムデータ

第8章 非識別化健康データ市場 - 展開モード別

  • 概要
    • セグメントシェア分析：展開モード別
    • オンプレミス
    • クラウドベース

第9章 非識別化健康データ市場 - 用途別

  • 概要
    • セグメントシェア分析：用途別
    • ヘルスケア調査
    • 患者ケア
    • 人口健康管理
    • 医薬品開発

第10章 非識別化健康データ市場 - 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析 - 非識別化健康データ業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Aetion, Inc.
    • Agilent Technologies, Inc.
    • Allscripts Healthcare Solutions, Inc.
    • Cerner Corporation
    • Epic Systems Corporation
    • flatiron health, Inc.
    • GE Healthcare
    • IBM Watson Health
    • McKesson Corporation
    • Medidata Solutions, Inc.
    • Optum, Inc.
    • Oracle Corporation
    • Philips Healthcare
    • QuintilesIMS（IQVIA）
    • SAS Institute Inc.
    • Syapse, Inc.
    • その他

第12章 アナリストの全方位展望

目次
Product Code: ANV3995

REPORT HIGHLIGHT

De-identified Health Data Market size was valued at USD 7,549.09 Million in 2023, expanding at a CAGR of 9.20% from 2024 to 2032.

The de-identified health data market involves the collection, analysis, and sale of health data that has been stripped of personally identifiable information, ensuring patient confidentiality. As healthcare organizations increasingly seek insights from big data analytics to improve patient outcomes and operational efficiency, the demand for de-identified data is surging. Factors contributing to this growth include the rising emphasis on personalized medicine, which necessitates large datasets for effective analysis. Furthermore, initiatives promoting interoperability among health systems facilitate data sharing, enhancing the accessibility of de-identified health data. However, challenges such as data security concerns and regulatory compliance issues may hinder market growth. Opportunities exist in the expansion of artificial intelligence and machine learning technologies, which require extensive datasets for training algorithms. For instance, studies indicate that over 80% of healthcare providers plan to invest in analytics solutions by 2025, underscoring the increasing reliance on de-identified health data to drive innovation and improve healthcare delivery.

De-identified Health Data Market- Market Dynamics

Growing Focus on Personalized Medicine Drives Demand in the De-identified Health Data Market

The rising focus on personalized medicine is significantly propelling demand in the De-identified Health Data Market. As healthcare providers increasingly utilize patient data to tailor treatments, the need for de-identified health data has surged. According to a report from the U.S. Department of Health & Human Services, personalized medicine can lead to better patient outcomes and reduced healthcare costs. Additionally, initiatives like the All of Us Research Program aim to gather data from diverse populations to enhance individualized treatment approaches. Major tech firms, including IBM and Google, are investing in AI and analytics tools to leverage de-identified health data for research and clinical applications, facilitating advancements in personalized therapies. This growing trend highlights the critical role of secure and compliant data handling in improving healthcare services while maintaining patient privacy.

De-identified Health Data Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.20% over the forecast period (2024-2032)

Based on Data Type segmentation, Electronic Health Records was predicted to show maximum market share in the year 2023

Based on Deployment Mode segmentation, Cloud-Based was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

De-identified Health Data Market- Segmentation Analysis:

The Global De-identified Health Data Market is segmented on the basis of Data Type, Deployment Mode, Application, and Region.

The market is divided into four categories based on data type: electronic health records (EHR) are the highest priority due to their comprehensive patient information. Following closely are Claims Data, which provides insights into healthcare costs, Clinical Data, and Genomic Data, which offers specialized insights.

The market is divided into two categories based on Deployment Mode: On-Premise and Cloud-Based. Cloud-based deployment is prioritized due to its scalability and cost-effectiveness, allowing easier access to data. On-premise solutions follow, favored for enhanced security and control over sensitive health information, though they require more investment.

De-identified Health Data Market- Geographical Insights

In North America, the De-identified Health Data Market is led by the United States, which is home to numerous healthcare data companies and advanced analytics firms. The U.S. generated approximately $22 billion in health data revenue in 2022, showcasing the significant investment in data-driven healthcare solutions. In Europe, the market is growing due to the European Union's General Data Protection Regulation (GDPR), which encourages the responsible use of de-identified data, allowing countries like Germany and the UK to expand their healthcare analytics capabilities. Meanwhile, the Asia Pacific region is emerging as a strong contender, with countries like India and China focusing on digital health initiatives. India's healthcare IT sector is projected to grow to $9 billion by 2025, indicating a rising demand for de-identified health data. Latin America is also recognizing the importance of health data, with Brazil implementing health data laws that facilitate de-identified data use for public health improvements. These regional initiatives are reshaping the de-identified health data landscape globally.

De-identified Health Data Market- Competitive Landscape:

In the De-identified Health Data Market, North America remains the leading region, driven by technological advancements and robust healthcare systems. In January 2023, Optum, a health services company, announced a strategic partnership with a leading analytics firm to enhance its de-identified health data offerings, aiming to provide advanced insights to healthcare providers. Meanwhile, in Europe, a significant collaboration occurred in March 2023 between Siemens Healthineers and a European analytics company to leverage de-identified patient data for research purposes, enhancing patient outcomes. In the Asia Pacific, a notable merger took place in late 2022 when a prominent health tech startup acquired a local data analytics firm, expanding its capabilities in de-identified health data management. Additionally, the growth of the de-identified health data market is supported by favorable regulations, with the U.S. Office of the National Coordinator for Health Information Technology promoting the responsible use of health data. These developments reflect the competitive landscape's dynamic nature, emphasizing innovation and collaboration across the globe.

Recent Developments:

In February 2023, Mayo Clinic Platform and TripleBlind expanded their partnership to enhance de-identified data usage and patient privacy. This collaboration aims to improve global health outcomes by enabling secure data analysis without compromising patient information or intellectual property rights.

In April 2023, Philips and MIT's IMES enhanced the eICU Collaborative Research Database, providing researchers access to de-identified data from over 200,000 critical care patients. This initiative aims to advance AI in healthcare and improve clinical understanding and patient outcomes.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DE-IDENTIFIED HEALTH DATA MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Aetion, Inc.
  • Agilent Technologies, Inc.
  • Allscripts Healthcare Solutions, Inc.
  • Cerner Corporation
  • Epic Systems Corporation
  • flatiron health, Inc.
  • GE Healthcare
  • IBM Watson Health
  • McKesson Corporation
  • Medidata Solutions, Inc.
  • Optum, Inc.
  • Oracle Corporation
  • Philips Healthcare
  • QuintilesIMS (IQVIA)
  • SAS Institute Inc.
  • Syapse, Inc.
  • Others

GLOBAL DE-IDENTIFIED HEALTH DATA MARKET, BY DATA TYPE- MARKET ANALYSIS, 2019 - 2032

  • Electronic Health Records (EHR)
  • Claims Data
  • Clinical Data
  • Genomic Data

GLOBAL DE-IDENTIFIED HEALTH DATA MARKET, BY DEPLOYMENT MODE- MARKET ANALYSIS, 2019 - 2032

  • On-Premise
  • Cloud-Based

GLOBAL DE-IDENTIFIED HEALTH DATA MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Healthcare Research
  • Patient Care
  • Population Health Management
  • Drug Development

GLOBAL DE-IDENTIFIED HEALTH DATA MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. De-identified Health Data Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. De-identified Health Data Market Snippet by Data Type
    • 2.1.2. De-identified Health Data Market Snippet by Deployment Mode
    • 2.1.3. De-identified Health Data Market Snippet by Application
    • 2.1.4. De-identified Health Data Market Snippet by Country
    • 2.1.5. De-identified Health Data Market Snippet by Region
  • 2.2. Competitive Insights

3. De-identified Health Data Key Market Trends

  • 3.1. De-identified Health Data Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. De-identified Health Data Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. De-identified Health Data Market Opportunities
  • 3.4. De-identified Health Data Market Future Trends

4. De-identified Health Data Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. De-identified Health Data Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. De-identified Health Data Market Landscape

  • 6.1. De-identified Health Data Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. De-identified Health Data Market - By Data Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Data Type, 2023 & 2032 (%)
    • 7.1.2. Electronic Health Records (EHR)
    • 7.1.3. Claims Data
    • 7.1.4. Clinical Data
    • 7.1.5. Genomic Data

8. De-identified Health Data Market - By Deployment Mode

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Deployment Mode, 2023 & 2032 (%)
    • 8.1.2. On-Premise
    • 8.1.3. Cloud-Based

9. De-identified Health Data Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Healthcare Research
    • 9.1.3. Patient Care
    • 9.1.4. Population Health Management
    • 9.1.5. Drug Development

10. De-identified Health Data Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. De-identified Health Data Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. De-identified Health Data Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. De-identified Health Data Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. De-identified Health Data Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. De-identified Health Data Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Data Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Deployment Mode, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- De-identified Health Data Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Aetion, Inc.
    • 11.2.2. Agilent Technologies, Inc.
    • 11.2.3. Allscripts Healthcare Solutions, Inc.
    • 11.2.4. Cerner Corporation
    • 11.2.5. Epic Systems Corporation
    • 11.2.6. flatiron health, Inc.
    • 11.2.7. GE Healthcare
    • 11.2.8. IBM Watson Health
    • 11.2.9. McKesson Corporation
    • 11.2.10. Medidata Solutions, Inc.
    • 11.2.11. Optum, Inc.
    • 11.2.12. Oracle Corporation
    • 11.2.13. Philips Healthcare
    • 11.2.14. QuintilesIMS (IQVIA)
    • 11.2.15. SAS Institute Inc.
    • 11.2.16. Syapse, Inc.
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us